Drug maker AbbVie reports 'excellent' third quarter
October 29, 2021 at 10:28 AM EDT
Increased sales of its Humira, Skyrizi and Rinvoq immunology drugs contributed to the good quarter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|